The 20 Best Bladder Cancer Doctors Near Me
Find Doctors who have experience with Hexaminolevulinate
Einstein Urology At Moss
Edouard Trabulsi is an Oncologist practicing medicine in Philadelphia, Pennsylvania. Dr. Trabulsi is rated as an Elite provider by MediFind in the treatment of Bladder Cancer. He is also highly rated in 17 other conditions, according to our data. His clinical expertise encompasses Prostate Cancer, Bladder Cancer, Muscle Invasive Bladder Cancer, Prostatectomy, and Nephrectomy. Dr. Trabulsi is board certified in Urology. Dr. Trabulsi is currently accepting new patients.
Prostate Cancer Center
Dr. Sima Porten is a specialist in cancers of the genital and urinary organs. She is a member of the urologic oncology team at the UCSF Helen Diller Family Comprehensive Cancer Center. Her clinical interests include the diagnosis and treatment of genitourinary cancer, particularly bladder cancer, upper tract urothelial cancer, kidney cancer and high-risk prostate cancer. Porten's research focuses mainly on the diagnosis and management of urothelial carcinoma, a cancer involving parts of the kidney, bladder and ureter (the tube connecting each kidney to the bladder). In studying the biologic or genetic basis of urothelial carcinoma, she hopes to develop new tests and treatments to bring personalized medicine to patients with bladder cancer. Porten received her undergraduate, medical and master of public health degrees from Northwestern University. During medical school, she was inducted into the Alpha Omega Alpha Honor Medical Society and also completed a fellowship through the Howard Hughes Medical Institute–National Institutes of Health Research Scholars Program. She then completed her urology residency training at UCSF, where she received the Julius R. Krevans Award for Clinical Excellence. During her training in urologic oncology at the University of Texas MD Anderson Cancer Center, she was awarded a John Quale Travel Fellowship for her research in bladder cancer. Porten is an active member of the American Urological Association, American Society of Clinical Oncology, Society of Women in Urology and Society of Urologic Oncology. Dr. Porten is rated as an Elite provider by MediFind in the treatment of Bladder Cancer. She is also highly rated in 12 other conditions, according to our data. Her clinical expertise encompasses Bladder Cancer, Urothelial Cancer, Non-Muscle Invasive Bladder Cancer, Nephrectomy, and Reconstructive Urology Surgery. Dr. Porten is board certified in American Board Of Urology, Urology. Dr. Porten is currently accepting new patients.
UT MD Anderson Cancer Center
Ashish Kamat is a Urologist practicing medicine in Cary, North Carolina. Dr. Kamat is rated as an Elite provider by MediFind in the treatment of Bladder Cancer. He is also highly rated in 15 other conditions, according to our data. His clinical expertise encompasses Bladder Cancer, Muscle Invasive Bladder Cancer, Non-Muscle Invasive Bladder Cancer, Cystectomy, and Lymphadenectomy.
Are you looking for a specific type of Bladder Cancer?
Common conditions include: Muscle Invasive Bladder Cancer, Non-Muscle Invasive Bladder Cancer
NYU Langone Internal Medicine Associates
William Huang is a Urologist practicing medicine in New York, New York. Dr. Huang is rated as an Elite provider by MediFind in the treatment of Bladder Cancer. He is also highly rated in 25 other conditions, according to our data. His clinical expertise encompasses Renal Cell Carcinoma (RCC), Bladder Cancer, Prostate Cancer, Nephrectomy, and Cystectomy.
Michael Cookson is a Urologist practicing medicine in Oklahoma City, Oklahoma. Dr. Cookson is rated as an Elite provider by MediFind in the treatment of Bladder Cancer. He is also highly rated in 23 other conditions, according to our data. His clinical expertise encompasses Bladder Cancer, Muscle Invasive Bladder Cancer, Prostate Cancer, Cystectomy, and Nephrectomy. Dr. Cookson is board certified in American Board Of Urology , Oklahoma State Board Of Medical Licensure & Supervision, Drug Enforcement Administration , and Oklahoma Bureau Of Narcotics And Dangerous Drugs . Dr. Cookson is currently accepting new patients.
University Of Chicago Medical Center
Gary Steinberg is a Urologist practicing medicine in Chicago, Illinois. Dr. Steinberg is rated as an Elite provider by MediFind in the treatment of Bladder Cancer. He is also highly rated in 17 other conditions, according to our data. His clinical expertise encompasses Bladder Cancer, Muscle Invasive Bladder Cancer, Non-Muscle Invasive Bladder Cancer, Cystectomy, and Ureteral Reconstruction. Dr. Steinberg is currently accepting new patients.
Baylor Medicine At McNair - Urology
Seth P. Lerner, MD, is Professor of Urology and holds the Beth and Dave Swalm Chair in Urologic Oncology, in the Scott Department of Urology, Baylor College of Medicine. He is Director of Urologic Oncology and the Multidisciplinary Bladder Cancer Program and Faculty Group Practice Medical Director for the Urology Clinic. He earned his medical degree from Baylor College of Medicine, completed a surgical internship at Virginia Mason Hospital in Seattle, and returned to Baylor for his residency training. He completed a two-year fellowship at the University of Southern California in urologic oncology and reconstructive surgery under Peter Jones and Don Skinner before returning to join the full-time Baylor faculty in 1992. His clinical practice, education, and research activities are devoted to urologic oncology and particularly lower and upper tract urothelial cancer. Dr. Lerner is author of more than 160 peer-reviewed articles, and co-editor of a comprehensive Textbook of Bladder Cancer. Dr. Lerner is an active member of the prestigious American Association of Genitourinary surgeons and is listed routinely among America's Top Doctors and Best Doctors in America. He established and directs the multi-disciplinary Bladder Cancer Research Program at Baylor, and his research interests include use of selective estrogen receptor modulators for treatment of bladder cancer, gene therapy, targeted molecular therapeutics, and outcomes of radical cystectomy and pelvic lymphadenectomy. He has 22 years of experience as a clinical investigator for both NCI and industry funded clinical trials. He is the PI of the ongoing SWOG NCI Phase III trial comparing extended vs. standard pelvic lymphadenectomy at time of radical cystectomy for muscle invasive bladder cancer. He is active in the leadership of several national bladder cancer research enterprises including chair of the Local Bladder Cancer committee of SWOG, co-chair of the NCI's Bladder Cancer Task Force and the Analysis Working Group of The Cancer Genome Atlas Project for muscle invasive bladder cancer. He is very active in the Bladder Cancer Advocacy Network (BCAN) as a member of the Board of Directors, past chair of the Bladder Cancer Think Tank and co-chair of the management committee of the Bladder Cancer Research Network. Dr. Lerner is rated as an Elite provider by MediFind in the treatment of Bladder Cancer. He is also highly rated in 11 other conditions, according to our data. His clinical expertise encompasses Bladder Cancer, Urothelial Cancer, Muscle Invasive Bladder Cancer, Cystectomy, and Lymphadenectomy. Dr. Lerner is currently accepting new patients.
Johns Hopkins Outpatient Center
Dr. Max Kates is the R. Christian B. Evensen Professor and an associate professor of urology and oncology at the Brady Urological Institute at Johns Hopkins. He also directs the Division of Urologic Oncology for the Brady Urological Institute. Dr. Kates completed his undergraduate degree at Wesleyan University in Connecticut before pursuing his medical degree at Mount Sinai School of Medicine in New York. He then went on to train at Johns Hopkins for his urologic residency and Society of Urologic Oncology (SUO) fellowship. Dr. Kates has expertise in all areas of urologic oncology, with a particular emphasis on bladder and prostate cancer. With training in open, endoscopic, and robotic surgical approaches, Dr. Kates’ surgical philosophy is to assess the unique needs of each patient, and develop the right treatment plan for their malignancy. He is very hands on in his approach in the clinic and the operating room, and believes open communication with the patient, the patient’s family, and referring providers is key to ensuring a speedy recovery. As the clinical director of the bladder cancer multidisciplinary clinic, Dr. Kates works with the team at the Johns Hopkins Greenberg Bladder Cancer Institute to deliver a personalized approach to bladder cancer utilizing cutting edge precision medicine approaches. Dr. Kates’ research interests involve novel treatments for cancers of the urinary tract. Dr. Kates has authored more than 135 journal articles in the fields of bladder, prostate, and kidney cancer. He currently has a provisional patent for a novel intravesical chemotherapy developed with nano-engineer collaborators. Additionally, Dr. Kates has made important discoveries into the mechanism of action of intravesical BCG, the most common treatment for bladder cancer. He is the principal investigator on multiple trials, and is currently leading EA8212 BRIDGE, which is a randomized trial open in over 150 centers in the United States comparing BCG to GemDoce chemotherapy for early stage bladder cancer. To inquire about an appointment or make a referral, Dr. Kates can be contacted by phone (410) 614-0009. Dr. Kates is rated as an Elite provider by MediFind in the treatment of Bladder Cancer. He is also highly rated in 14 other conditions, according to our data. His clinical expertise encompasses Bladder Cancer, Urothelial Cancer, Muscle Invasive Bladder Cancer, Cystectomy, and Nephrectomy. Dr. Kates is board certified in American Board Of Urology. Dr. Kates is currently accepting new patients.
Jefferson Urology – Honickman Center
Leonard Gomella is an Oncologist and a General Surgeon practicing medicine in Philadelphia, Pennsylvania. Dr. Gomella is rated as a Distinguished provider by MediFind in the treatment of Bladder Cancer. He is also highly rated in 9 other conditions, according to our data. His clinical expertise encompasses Prostate Cancer, Bladder Cancer, Familial Prostate Cancer, Prostatectomy, and Cystectomy. Dr. Gomella is board certified in Urology. Dr. Gomella is currently accepting new patients.
UT Southwestern - Urology
Vitaly Margulis is a Urologist practicing medicine in Dallas, Texas. Dr. Margulis is rated as an Elite provider by MediFind in the treatment of Bladder Cancer. He is also highly rated in 43 other conditions, according to our data. His clinical expertise encompasses Upper Tract Urothelial Carcinoma (UTUC), Urothelial Cancer, Renal Cell Carcinoma (RCC), Nephrectomy, and Orchiectomy. Dr. Margulis is currently accepting new patients.
Southern Sierra Medical Clinic
Anne Schuckman is a Urologist practicing medicine in Ridgecrest, California. Dr. Schuckman is rated as an Elite provider by MediFind in the treatment of Bladder Cancer. She is also highly rated in 25 other conditions, according to our data. Her clinical expertise encompasses Bladder Cancer, Urothelial Cancer, Muscle Invasive Bladder Cancer, Cystectomy, and Bladder Reconstruction. Dr. Schuckman is currently accepting new patients.
CUIMC/Herbert Irving Pavilion
James McKiernan, MD, is the John K. Lattimer Professor of Urology and CEO of ColumbiaDoctors. He is also Senior Vice Dean for Clinical Affairs for Columbia University Vagelos College of Physicians and Surgeons. Dr. McKiernan graduated from Johns Hopkins University with a BA in biology and received his MD from Columbia University College of Physicians and Surgeons. He completed his training in urology and general surgery at NewYork-Presbyterian Hospital, followed by a urologic surgical oncology fellowship at Memorial Sloan-Kettering Cancer Center. Dr. McKiernan's clinical practice is focused on urologic oncology and particularly on surgical therapy in high-risk patients with bladder and kidney cancers. Dr. McKiernan evaluates and treats over 1,000 patients with bladder cancer every year. His research, funded by NIH and biotechnology industry grants, focuses on developing novel therapeutics for bladder cancer treatment as well as comparative effectiveness research in urologic oncology. In the management of kidney and bladder cancer, he has special expertise in organ preservation and reconstructive surgery to maximize quality of life. Dr. McKiernan's research has been published in Cancer, Cancer Research, the Journal of Clinical Oncology, JAMA Oncology, Journal of Urology, Urologic Oncology, and Urology. He has authored and co-authored more than 220 scientific articles and book chapters on urologic cancer and related issues.For the past 10 years, he has directed a research team at Columbia University Medical Center investigating quality outcomes and effectiveness in urologic cancer surgery. He has served as the Vice Chairman for the AJCC TNM Staging Task Force, Co-Chair of the AUA Guidelines Panel on non-muscle invasive bladder cancer, as well as on the American Board of Urology and Society of Urologic Oncology Examination Committees. In addition, Dr. McKiernan is the principal investigator of the NIH-funded clinical trials program of experimental therapeutics in bladder cancer at Columbia University/NYPH, which is investigating new agents for bladder preservation in patients whose cancer has recurred after standard therapy. In collaboration with researchers at Columbia's Herbert Irving Comprehensive Cancer Center, his team continues to develop new therapeutic strategies for managing bladder cancer. Dr. Mckiernan is rated as an Elite provider by MediFind in the treatment of Bladder Cancer. He is also highly rated in 25 other conditions, according to our data. His clinical expertise encompasses Bladder Cancer, Muscle Invasive Bladder Cancer, Urothelial Cancer, Cystectomy, and Nephrectomy. Dr. Mckiernan is board certified in Urology. Dr. Mckiernan is currently accepting new patients.
Arnulf Stenzl practices practicing medicine in Tuebingen, Germany. Mr. Stenzl is rated as an Elite expert by MediFind in the treatment of Bladder Cancer. He is also highly rated in 24 other conditions, according to our data. His clinical expertise encompasses Bladder Cancer, Prostate Cancer, Renal Cell Carcinoma (RCC), Cystectomy, and Lymphadenectomy.
Medical Pavilion
Jeffrey Holzbeierlein is an Oncologist practicing medicine in Kansas City, Kansas. Dr. Holzbeierlein is rated as an Elite provider by MediFind in the treatment of Bladder Cancer. He is also highly rated in 22 other conditions, according to our data. His clinical expertise encompasses Bladder Cancer, Muscle Invasive Bladder Cancer, Non-Muscle Invasive Bladder Cancer, Nephrectomy, and Reconstructive Urology Surgery. Dr. Holzbeierlein is board certified in American Board Of Urology, Urology - 2004. Dr. Holzbeierlein is currently accepting new patients.
Cedars-Sinai Urology-Los Angeles
Stephen Freedland is a Urologist practicing medicine in Los Angeles, California. Dr. Freedland is rated as an Elite provider by MediFind in the treatment of Bladder Cancer. He is also highly rated in 12 other conditions, according to our data. His clinical expertise encompasses Prostate Cancer, Familial Prostate Cancer, Enlarged Prostate (BPH), Prostatectomy, and Cystectomy.
Prostate Cancer Center
Dr. Maxwell Meng is a surgeon specializing in urologic cancers and laparoscopy. His interests in patient care include diagnosing and managing cancers of the genital and urinary organs, as well as minimally invasive treatments of both benign and malignant diseases. He is experienced in robotic surgery. Meng is active in research to develop new treatment technologies. Meng earned his medical degree at Johns Hopkins School of Medicine. He completed general surgery and urology training at UCSF, where he also completed fellowships in urologic oncology and minimally invasive surgery. Dr. Meng is rated as an Elite provider by MediFind in the treatment of Bladder Cancer. He is also highly rated in 21 other conditions, according to our data. His clinical expertise encompasses Bladder Cancer, Renal Cell Carcinoma (RCC), Urothelial Cancer, Nephrectomy, and Reconstructive Urology Surgery. Dr. Meng is board certified in American Board Of Urology, Urology. Dr. Meng is currently accepting new patients.
Allina Health Cancer Institute - Minneapolis
What is your practice philosophy?Patient focused, evidenced based care tailored to the patient and family values and needs. Dr. Konety is rated as an Elite provider by MediFind in the treatment of Bladder Cancer. He is also highly rated in 11 other conditions, according to our data. His clinical expertise encompasses Bladder Cancer, Muscle Invasive Bladder Cancer, Prostate Cancer, Lymphadenectomy, and Endoscopy. Dr. Konety is board certified in American Board Of Urology,2003 and Urology. Dr. Konety is currently accepting new patients.
Office
Siamak Daneshmand is a Urologist practicing medicine in Los Angeles, California. Dr. Daneshmand is rated as an Elite provider by MediFind in the treatment of Bladder Cancer. He is also highly rated in 40 other conditions, according to our data. His clinical expertise encompasses Bladder Cancer, Muscle Invasive Bladder Cancer, Testicular Cancer, Cystectomy, and Bladder Reconstruction.
JPS Health Network
Yair Lotan is a Urologist practicing medicine in Fort Worth, Texas. Dr. Lotan is rated as an Elite provider by MediFind in the treatment of Bladder Cancer. He is also highly rated in 44 other conditions, according to our data. His clinical expertise encompasses Bladder Cancer, Urothelial Cancer, Upper Tract Urothelial Carcinoma (UTUC), Cystectomy, and Nephrectomy.
Penn Urology Perelman
Trinity Bivalacqua is a Urologist practicing medicine in Philadelphia, Pennsylvania. Dr. Bivalacqua is rated as an Elite provider by MediFind in the treatment of Bladder Cancer. He is also highly rated in 24 other conditions, according to our data. His clinical expertise encompasses Bladder Cancer, Muscle Invasive Bladder Cancer, Urothelial Cancer, Cystectomy, and Prostatectomy.
Last Updated: 11/08/2026










